These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 12399192

  • 1. Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.
    Griffin KF, Eyles JE, Spiers ID, Alpar HO, Williamson ED.
    Vaccine; 2002 Nov 01; 20(31-32):3650-7. PubMed ID: 12399192
    [Abstract] [Full Text] [Related]

  • 2. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED.
    Vaccine; 2004 Oct 22; 22(31-32):4365-73. PubMed ID: 15474730
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.
    FEMS Immunol Med Microbiol; 2003 Oct 15; 38(3):215-29. PubMed ID: 14522457
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A single dose sub-unit vaccine protects against pneumonic plague.
    Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW.
    Vaccine; 2000 Oct 15; 19(4-5):566-71. PubMed ID: 11027822
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED, Flick-Smith HC, Waters E, Miller J, Hodgson I, Le Butt CS, Hill J.
    Microb Pathog; 2007 Jan 15; 42(1):11-21. PubMed ID: 17107769
    [Abstract] [Full Text] [Related]

  • 10. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.
    Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW.
    Clin Exp Immunol; 1999 Apr 15; 116(1):107-14. PubMed ID: 10209513
    [Abstract] [Full Text] [Related]

  • 11. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE, Butcher WA, Titball RW, Hill J.
    Vaccine; 2007 Oct 16; 25(42):7301-6. PubMed ID: 17869388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
    Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW.
    Infect Immun; 2008 Oct 16; 76(10):4564-73. PubMed ID: 18694965
    [Abstract] [Full Text] [Related]

  • 14. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
    Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.
    Vaccine; 2006 Mar 06; 24(10):1625-32. PubMed ID: 16243411
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V, Chitralekha KT, Bakshi AR, Tomar D, Deshmukh RA, Baig MA, Rao DN.
    Vaccine; 2006 Apr 12; 24(16):3279-89. PubMed ID: 16476510
    [Abstract] [Full Text] [Related]

  • 17. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.
    Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW.
    Vaccine; 1997 Jul 12; 15(10):1079-84. PubMed ID: 9269050
    [Abstract] [Full Text] [Related]

  • 18. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits.
    Eyles JE, Williamson ED, Spiers ID, Stagg AJ, Jones SM, Alpar HO.
    J Control Release; 2000 Jan 03; 63(1-2):191-200. PubMed ID: 10640592
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ.
    Vaccine; 2016 Nov 11; 34(47):5768-5776. PubMed ID: 27745954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.